COMMUNIQUÉS West-GlobeNewswire

Adherium to Present at the Chardan Digital Health Conference on Tuesday, May 22, 2018
15/05/2018
SAN MATEO, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), an award-winning digital health company that improves medication adherence and patient outcomes, today announced the Company will be participating [...]
Interpace Diagnostics Group Reports First Quarter 2018 Financial Results, Business Progress and Recent Accomplishments
15/05/2018
Revenue Grew 39% Over the Prior Year’s Quarter and 10% Over the Prior Period Record Quarterly Revenue of $4.8 Million and Record Quarterly Cash Receipts of $4.4 Million Cash & Cash Equivalents Remain Strong at $12.6 [...]
Inovio HIV Vaccine, Which Generated Near 100% Immune Responses, Sustained Durable Memory Responses Measured One Year After The Start of Clinical Trial
15/05/2018
PENNVAX®-GP generated among highest levels of immune responses ever demonstrated in a human HIV vaccine study PLYMOUTH MEETING, Pa., May 15, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) today [...]
Progressive Care Inc. Reports Largest Single Revenue Quarter in Company History
15/05/2018
Florida-Based Healthcare, Technology and Tele-Pharmacy Services Provider Shows 24% Increase in Prescriptions Filled Reports March 2018 Revenue of $1.9M as Largest Single Month in Company History MIAMI, May 15, 2018 ( [...]
Emerald Health Therapeutics Announces $16.8 Million Prospectus Sale; Concurrent Secondary Sale
15/05/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VICTORIA, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (TSXV:EMH) ("Emerald" or [...]
Arch Therapeutics to Provide Corporate Update at the 8th LD Micro Invitational on Monday, June 4, 2018
15/05/2018
FRAMINGHAM, Mass., May 15, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB:ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will be featured as a [...]
Affimed Reports Financial Results for First Quarter 2018
15/05/2018
Heidelberg, Germany, May 15, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial results [...]
Trading by management and close relations of management
15/05/2018
Read the full announcement in the attached file Attachment 2018_32_Trading_by_management_EN
Cannabis Wheaton Income Corp. Provides FV Pharma Inc. Facility Development Update
15/05/2018
VANCOUVER, British Columbia, May 15, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (TSX.V:CBW) (" Cannabis Wheaton " or the " Company ") is pleased to provide the following development update on the joint [...]
Cutera to Present at Jefferies Global Healthcare Conference
15/05/2018
BRISBANE, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- Cutera, Inc. (Nasdaq: CUTR ), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, announced today that James Reinstein, [...]
Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting
15/05/2018
SALT LAKE CITY, May 15, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ: MYGN ), a leader in molecular diagnostics and personalized medicine, today announced that it will present results from eight studies at [...]
XOMA to Present at the UBS Global Healthcare Conference
15/05/2018
EMERYVILLE, Calif., May 15, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA ), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal, Chief Executive [...]
Bellicum Announces Oral Presentation on Dual-Switch CAR-T Technology at the 21st Annual Meeting of the American Society of Gene and Cell Therapy
15/05/2018
HOUSTON, May 15, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (Nasdaq: BLCM ), a leader in developing novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders, today [...]
Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates
15/05/2018
Conference call at 8:30 a.m. EDT, Tuesday, May 15, 2018 RUTHERFORD, N.J., May 15, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular [...]
Xenon Presents Positive XEN1101 TMS Pharmacodynamic Phase 1 Data at 14th Eilat Conference
15/05/2018
Company to Hold Conference Call at 8:00 am ET Today XEN1101 Pilot TMS-EEG Data Demonstrates Statistically Significant Effect of 20mg Dose versus Baseline (p<0.01) and Greater Effect on TMS-EMG Resting Motor Threshold [...]
Xenon Presents XEN901 Phase 1 Clinical Update and Supporting Pre-clinical Data at 14th Eilat Conference
15/05/2018
Company to Hold Conference Call at 8:00 am ET Today Preliminary Phase 1 Clinical Data Support Drug Exposure Levels Higher than Required in Pre-clinical Efficacy Models with Excellent Tolerability and Safety New Pre- [...]
PotNetwork Holdings, Inc. Exceeds $2 Million in Revenues in April 2018, Realizing a 98% Increase Over April 2017
15/05/2018
Reflecting the Company’s Commitment to Excellence in Research, Innovation and Consumer Satisfaction, Exponential Results Continue FT LAUDERDALE, Fla., May 15, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork [...]
Invivoscribe Releases the LymphoTrack Dx TRB Assay as CE-Marked IVD Kit, Completing the NGS Clonality Suite for the MiSeq Platform
15/05/2018
SAN DIEGO, May 15, 2018 (GLOBE NEWSWIRE) -- Invivoscribe Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized [...]
Transactions in relation to share buyback program
15/05/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]

Pages